Hyperhomocysteinemia and lipid peroxidation in stable coronary heart disease
Aim. To compare homocysteine, lipids, and lipid peroxidation (LP) products’ levels in plasma of coronary heart disease (CHD) patients with stable angina and dyslipidemia, and relatively healthy individuals. Material and methods. The study included 30 CHD patients (Functional Class, FC, II-III angina...
Saved in:
| Main Authors: | O. L. Belaya, N. V. Fedorova, I. G. Fomina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2007-02-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1142 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antioxidant status and lipid peroxidation in stable coronary heart disease patients with dyslipidemia
by: O. L. Belaya, et al.
Published: (2006-10-01) -
Hyperhomocysteinemia prevalence among patients with venous thromboembolism
by: R. Ben Salah, et al.
Published: (2024-12-01) -
Lipid peroxidation, antioxidant protection, and rheology disturbances in coronary heart disease pathogenesis
by: A. N. Zakirova, et al.
Published: (2006-04-01) -
Hyperhomocysteinemia as a risk factor for the development of pathological changes in the cardiovascular system: Mechanisms and consequences
by: Todorović Dušan, et al.
Published: (2024-01-01) -
A study of the degree of inflammatory response of atherosclerotic plaque in the coronary artery in patients with impaired metabolism of homocysteine and vitamin D
by: O. S. Nykonenko, et al.
Published: (2020-12-01)